Metastatic pancreatic neuroendocrine tumor
Clinical trials for Metastatic pancreatic neuroendocrine tumor explained in plain language.
Never miss a new study
Get alerted when new Metastatic pancreatic neuroendocrine tumor trials appear
Sign up with your email to follow new studies for Metastatic pancreatic neuroendocrine tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive therapy vs chemotherapy: which works better for pancreatic NETs?
Disease control OngoingThis trial compares two treatment approaches for pancreatic neuroendocrine tumors that have spread or cannot be removed surgically. One group receives lutetium Lu 177 dotatate, a radioactive drug that targets tumor cells, while the other receives a combination of chemotherapy dru…
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC